Origin Agritech Limited (NASDAQ:SEED) (“Origin” or the “Company”)
, a technology-focused supplier of crop seeds and agricultural products in China, today announced that Dr. James Chen will join Origin’s executive management team as the Chief Financial Officer.
Dr. Chen served as an Investment Manager at Abu Dhabi Investment Authority (ADIA), the sovereign wealth fund owned by the Government of Abu Dhabi. In his investment manager capacity, Dr. Chen played a key role in helping ADIA manage equity investment in China related portfolios. After joining ADIA in 2008, he contributed significantly in setting up China A-Share QFII Fund and achieved consistent benchmark-beating performance since the fund’s inception. Prior to ADIA, Dr. Chen spent over five years in Sell-Side research, most recently as a Senior Research Analyst at Morgan Joseph and previously at BB&T Capital Markets and Fulcrum Global Partners. He was a member of a top-ranked analyst team rated by Institutional Investors Journal and Wall Street Journal for their collective coverage in such companies as Dow Chemicals, Du Pont and Monsanto. Dr. Chen started his career at Univation Technologies, a joint venture between Exxon Mobile and Dow Chemical.
“With his balanced experience in capital markets and global chemical industries, James is uniquely qualified to lead our financial operations in the current global macro environment. We are very excited to welcome him to Origin,” said Dr. Gengchen Han, Origin’s Chairman, President and CEO. “With key leadership transitions in place, we are now well positioned to expand our leadership in China’s hybrid crop seeds market and continue the development and commercial application of our GMO portfolio.”
Dr. Chen is a Chartered Financial Analyst. He received a Bachelor’s Degree from East China University of Science and Technology and an M.B.A. from New York University. Dr. Chen received his Ph.D. Degree in Chemical Engineering from University of Connecticut.